Both in Pharmaceuticals
Amphastar Pharmaceuticals vs Seaport Therapeutics
Over the past year AMPH returned +17.8% and SPTX returned −10.2%; their daily moves had a correlation of -0.20.
AMPH +17.8% SPTX −10.2%Growth of $1, one year, split-adjusted
| Metric | AMPH | SPTX |
|---|---|---|
| Price | $28.02 | $20.96 |
| Market cap | $1.19B | $1.12B |
| Today | +3.32% | +3.76% |
| 1 month | +8.1% | +20.7% |
| 6 months | +17.2% | — |
| Year to date | +4.6% | — |
| 1 year | +10.8% | — |
| Revenue growth (YoY) | +5.4% | — |
| Gross margin | 50.8% | — |
| Net margin | 16.5% | — |
| P/E (TTM) | 15.2× | — |
| Price / sales | 1.6× | — |
| Net cash | -$321.9M | $290.4M |
| Dividend yield | — | — |
| Volatility (60d) | 31.3% | — |
| Short % of float | 14.9% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).